Skip to main content
⌘K
·
Launch Terminal
Launch Terminal
Home
SEC Filings
Home
SEC Filings
Filings
Filing Date
Form Type
Company
Description
AI
Link
Learn
MCP
API
Cookie Preferences
Material events
Financial results
Capital raises
Insider transactions
Fund filings
Advanced filters
Any time
Sort
Filings
Filing Date
Form Type
Company
Description
AI
Link
Browse AI-analysed SEC filings
Page 3 of 73 · 7,256 total
BOF: 424B5 · prospectus supplement
BOF · 424B5 · 2026-10-23
PERF: 6-K · acquisition merger
PERF · 6-K · 2026-10-23
AYI: 10-K · periodic report
AYI · 10-K · 2026-10-23
FISV: 8-K · leadership change
FISV · 8-K · 2026-10-23
LKQ: 8-K · leadership change
LKQ · 8-K · 2026-10-23
AMR: 8-K · earnings release
AMR · 8-K · 2026-10-23
FHB: 8-K · earnings release
FHB · 8-K · 2026-10-23
NJR: 8-K · debt financing
NJR · 8-K · 2026-10-23
GNTX: 8-K · earnings release
GNTX · 8-K · 2026-10-23
RBCAA: 8-K · earnings release
RBCAA · 8-K · 2026-10-23
BANL: 6-K · offering registration
BANL · 6-K · 2026-10-23
NEUP: 8-K · material agreement
NEUP · 8-K · 2026-10-23
CLIK: 6-K · foreign private issuer
CLIK · 6-K · 2026-10-23
RTCJF: 20-F · periodic report
RTCJF · 20-F · 2026-10-23
DOW: 10-Q · periodic report
DOW · 10-Q · 2026-10-23
LPL: 6-K · other
LPL · 6-K · 2026-10-23
WRLD: 8-K · earnings release
WRLD · 8-K · 2026-10-23
CEPU: 6-K · share repurchase
CEPU · 6-K · 2026-10-23
IMTX: 6-K · clinical trial
IMTX · 6-K · 2026-10-23
IPM: 8-K · material agreement
IPM · 8-K · 2026-10-23
RITM: 8-K · earnings release
RITM · 8-K · 2026-10-23
BCPC: 8-K · earnings release
BCPC · 8-K · 2026-10-23
EMBJ: 6-K · foreign private issuer
EMBJ · 6-K · 2026-10-23
PM: 10-Q · periodic report
PM · 10-Q · 2026-10-23
BLRX: 6-K · clinical trial
BLRX · 6-K · 2026-10-23
SLB: 8-K · earnings release
SLB · 8-K · 2026-10-23
BCS: 6-K · share repurchase
BCS · 6-K · 2026-10-23
JAKK: 8-K · earnings release
JAKK · 8-K · 2026-10-23
AXP: 8-K · earnings release
AXP · 8-K · 2026-10-23
ATHM: 6-K · other
ATHM · 6-K · 2026-10-23
SPRC: 6-K · clinical trial
SPRC · 6-K · 2026-10-23
GLDG: 6-K · other
GLDG · 6-K · 2026-10-23
BAH: 10-Q · periodic report
BAH · 10-Q · 2026-10-23
BAH: 8-K · earnings release
BAH · 8-K · 2026-10-23
EAF: 8-K · earnings release
EAF · 8-K · 2026-10-23
FCNCA: 8-K · earnings release
FCNCA · 8-K · 2026-10-23
MKTX: 8-K · earnings release
MKTX · 8-K · 2026-10-23
JKS: 424B3 · prospectus supplement
JKS · 424B3 · 2026-10-23
USAS: 6-K · other
USAS · 6-K · 2026-10-23
NTPIF: 6-K · debt financing
NTPIF · 6-K · 2026-10-23
IMMP: 20-F · periodic report
IMMP · 20-F · 2026-10-23
WF: 6-K · share repurchase
WF · 6-K · 2026-10-23
WF: 6-K · dividend
WF · 6-K · 2026-10-23
ALV: 8-K · earnings release
ALV · 8-K · 2026-10-23
WF: 6-K · earnings release
WF · 6-K · 2026-10-23
QGEN: 6-K · acquisition merger
QGEN · 6-K · 2026-10-23
JBDI: 6-K · proxy statement
JBDI · 6-K · 2026-10-23
ZYME: 8-K · material agreement
ZYME · 8-K · 2026-10-23
ZLAB: 8-K · offering registration
ZLAB · 8-K · 2026-10-23
LIMX: 8-K · amendment
LIMX · 8-K · 2026-10-23
FLG: 8-K · earnings release
FLG · 8-K · 2026-10-23
ATHE: 6-K · offering registration
ATHE · 6-K · 2026-10-23
FRST: 8-K · earnings release
FRST · 8-K · 2026-10-23
MLCO: 6-K · material agreement
MLCO · 6-K · 2026-10-23
UYSC: 8-K · debt financing
UYSC · 8-K · 2026-10-23
ATHE: 6-K · other
ATHE · 6-K · 2026-10-23
KT: 6-K · litigation
KT · 6-K · 2026-10-23
GLOP-PB: 6-K · earnings release
GLOP-PB · 6-K · 2026-10-23
ATHE: 6-K · other
ATHE · 6-K · 2026-10-23
AMBR: 6-K · proxy statement
AMBR · 6-K · 2026-10-23
EVAX: 6-K · clinical trial
EVAX · 6-K · 2026-10-23
APXC: 6-K · prospectus supplement
APXC · 6-K · 2026-10-23
LNAI: 8-K · delisting
LNAI · 8-K · 2026-10-23
ANTA: 6-K · acquisition merger
ANTA · 6-K · 2026-10-23
APXC: 6-K · prospectus supplement
APXC · 6-K · 2026-10-23
OMC: 10-Q · periodic report
OMC · 10-Q · 2026-10-23
GPRK: 6-K · debt financing
GPRK · 6-K · 2026-10-23
CRML: 6-K · acquisition merger
CRML · 6-K · 2026-10-22
BBD: 6-K · share repurchase
BBD · 6-K · 2026-10-22
BBD: 6-K · share repurchase
BBD · 6-K · 2026-10-22
PUSA: 8-K · leadership change
PUSA · 8-K · 2026-10-23
BRQL: 8-K · debt financing
BRQL · 8-K · 2026-10-22
BOXL: S-1/A · offering registration
BOXL · S-1/A · 2026-10-23
WDC: 10-Q · periodic report
WDC · 10-Q · 2026-10-22
FMST: 6-K · material agreement
FMST · 6-K · 2026-10-23
WDAY: 424B5 · prospectus supplement
WDAY · 424B5 · 2026-10-23
RNG: 10-Q · periodic report
RNG · 10-Q · 2026-10-22
FAF: 10-Q · periodic report
FAF · 10-Q · 2026-10-22
RMIX: SCHEDULE 13D/A · ownership disclosure
RMIX · SCHEDULE 13D/A · 2026-10-22
SNES: SCHEDULE 13D/A · ownership disclosure
SNES · SCHEDULE 13D/A · 2026-10-22
KOP: SCHEDULE 13D/A · ownership disclosure
KOP · SCHEDULE 13D/A · 2026-10-22
GCTK: 8-K · debt financing
GCTK · 8-K · 2026-10-22
AXG: 424B5 · prospectus supplement
AXG · 424B5 · 2026-10-22
MOBX: 424B3 · material agreement
MOBX · 424B3 · 2026-10-22
MOBX: 424B3 · amendment
MOBX · 424B3 · 2026-10-22
CNL: 6-K · other
CNL · 6-K · 2026-10-22
MOBX: 424B3 · prospectus supplement
MOBX · 424B3 · 2026-10-22
AIHS: 8-K · acquisition merger
AIHS · 8-K · 2026-10-22
PAVM: 8-K · offering registration
PAVM · 8-K · 2026-10-22
AXG: 6-K · offering registration
AXG · 6-K · 2026-10-22
BE: 10-Q · periodic report
BE · 10-Q · 2026-10-22
BHM: 8-K · leadership change
BHM · 8-K · 2026-10-22
BWMX: 6-K · earnings release
BWMX · 6-K · 2026-10-22
NP: 10-Q · periodic report
NP · 10-Q · 2026-10-22
ENVA: 10-Q · periodic report
ENVA · 10-Q · 2026-10-22
DEVS: 8-K · acquisition merger
DEVS · 8-K · 2026-10-22
ENLV: 6-K · reverse split
ENLV · 6-K · 2026-10-22
ISTR: 8-K · earnings release
ISTR · 8-K · 2026-10-22
C: 8-K · leadership change
C · 8-K · 2026-10-22
LMT: 10-Q · periodic report
LMT · 10-Q · 2026-10-22
‹ Prev
1
2
3
4
5
6
8
12
16
20
24
28
32
36
40
44
48
52
56
60
64
68
72
73
Next ›
